The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Designed Extension of Studies Based on Conditional Power
Abstract
We propose a flexible method of extending a study based on conditional power. The possibility for extension when the p value at the planned end is small but not statistically significant is built in to the design of the study. The significance of the treatment difference at the planned end is used to determine the number of additional observations needed and the critical value necessary for use after accruing those additional observations. It may therefore be thought of as a two-stage procedure. Even though the observed treatment difference at stage 1 is used to make decisions, the Type I error rate is protected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Two-Sample Test for a Linear Hypothesis Whose Power is Independent of the Variance
Stein, C. (1945) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177731088 · Cited by 886
Brensike, J. F., Levy, R. I., Kelsey, S. F., Passamani, E. R., Richardson, J. M., Loh, I. K., Stone, N. J., Aldrich, R. F., Battaglini, J. W., & Moriarty, D. J. (1984) · Circulation · doi:10.1161/01.cir.69.2.313 · Cited by 668
The role of internal pilot studies in increasing the efficiency of clinical trials
Wittes, J., & Brittain, E. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090113 · Cited by 440
Stochastically curtailed tests in long–term clinical trials
Gordon Lan, K. K., Simon, R., & Halperin, M. (1982) · Communications in Statistics. Part C: Sequential Analysis · doi:10.1080/07474948208836014 · Cited by 354
The B-Value: A Tool for Monitoring Data
Lan, K. K. G., & Wittes, J. (1988) · Biometrics · doi:10.2307/2531870 · Cited by 303
Interim analyses for monitoring clinical trials that do not materially affect the type I error rate
Gould, A. L. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110107 · Cited by 145
Sequential monitoring of clinical trials: The role of information and brownian motion
Lan, K. K. G., & Zucker, D. M. (1993) · Statistics in Medicine · doi:10.1002/sim.4780120804 · Cited by 137
Effects of Assumption Violations on Type I Error Rate in Group Sequential Monitoring
Proschan, M. A., Follmann, D. A., & Waclawiw, M. A. (1992) · Biometrics · doi:10.2307/2532704 · Cited by 74
Self-citationGould, A. L., & Pecore, V. (1982) · Biometrika · doi:10.1093/biomet/69.1.75 · Cited by 57
Monitoring clinical trials with a conditional probability stopping rule
Snapinn, S. M. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110510 · Cited by 40
Conditional power for arbitrary survival curves to decide whether to extend a clinical trial
Henderson, W. G., Fisher, S. G., Weber, L., Hammermeister, K. E., & Sethi, G. K. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90027-j · Cited by 16
Cited by
Bretz, F., Hothorn, T., & Westfall, P. (2016) · doi:10.1201/9781420010909 · Cited by 1,233
Thromboelastography-Guided Transfusion Algorithm Reduces Transfusions in Complex Cardiac Surgery
Shore-Lesserson, L., Manspeizer, H. E., DePerio, M., Francis, S., Vela-Cantos, F., & Ergin, M. A. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199902000-00016 · Cited by 845
Adaptive designs in clinical trials: why use them, and how to run and report them
Pallmann, P., Bedding, A. W., Choodari-Oskooei, B., Dimairo, M., Flight, L., Hampson, L. V., Holmes, J., Mander, A. P., Odondi, L., Sydes, M. R., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1017-7 · Cited by 829
Adaptive Sample Size Calculations in Group Sequential Trials
Lehmacher, W., & Wassmer, G. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.01286.x · Cited by 598
Adaptive design methods in clinical trials–a review
Chow, S.-C., & Chang, M. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-11 · Cited by 482
Metadata
- Authors
- Proschan, M. A., & Hunsberger, S. A.
- Venue
- Biometrics
- Publisher
- JSTOR
- Published
- 1995-12
- Volume
- 51
- Issue
- 4
- Pages
- 1315
- ISSN
- 0006-341X (ISSN-L)
- OpenAlex
- W1986502618
- Cited by
- 534
- References
- 11
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.